Evolus Strengthens Balance Sheet; Secures $40 Million Investment
July 06, 2020 19:48 ET
|
Evolus
NEWPORT BEACH, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced that its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40 million in a...
Evolus Provides Update on United States International Trade Commission (USITC) Case
July 06, 2020 19:45 ET
|
Evolus
Commission to Review Case; Final Determination Targeted for November 2020 Jeuveau® Launch and Product Supply Unaffected by Initial Determination NEWPORT BEACH, Calif., July 06, 2020 (GLOBE...
Evolus Reports First Quarter 2020 Results and Provides Business Update
May 11, 2020 16:01 ET
|
Evolus
NEWPORT BEACH, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020
May 06, 2020 16:01 ET
|
Evolus
NEWPORT BEACH, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Provides Strategic Business Update
April 16, 2020 16:51 ET
|
Evolus
NEWPORT BEACH, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Provides Update on International Trade Commission (ITC) Case
March 04, 2020 09:08 ET
|
Evolus
NEWPORT BEACH, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today provided the following statement: “In several media reports this week, Medytox has made comments on the...
Evolus to Participate in Barclays 2020 Global Healthcare Conference
March 03, 2020 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update
February 25, 2020 07:00 ET
|
Evolus
Q4 2019 Net Revenue $19.5 Million, Up from $13.2 Million in Q3 2019 Jeuveau® Achieved Number Three Unit Share Position in the U.S. in 20191 Launched Evolux™; Only Practice Loyalty...
Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference
February 13, 2020 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020
February 12, 2020 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...